Optimer Pharma (OPTR) Names Stephen Webster as CFO
Tweet
Share
E-mailGet Alerts OPTR Hot Sheet
Join SI Premium – FREE
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) has appointed Stephen Webster as Chief Financial Officer. Mr. Webster will be responsible for directing Optimer's financial strategy, accounting and investor relations functions.
Prior to joining Optimer, Mr. Webster served as Chief Financial Officer of Adolor Corporation until its sale to Cubist Pharmaceuticals, Inc.
Prior to joining Optimer, Mr. Webster served as Chief Financial Officer of Adolor Corporation until its sale to Cubist Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Western Union chief legal officer to retire in November 2026
- Cleveland-Cliffs promotes CFO Celso Goncalves to president and board
- Allurion Technologies CEO resigns, COO to oversee operations
Create E-mail Alert Related Categories
Management ChangesRelated Entities
Cubist Pharmaceuticals Inc./Adolor Corp.Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
